Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-FR Version v1-EN
Language French English
Date Updated 2020-07-13 2020-06-04
Drug Identification Number 02460912 02460912
Brand name APO-PHENYTOIN SODIUM APO-PHENYTOIN SODIUM
Common or Proper name PHENYTOIN PHENYTOIN
Company Name AA PHARMA INC AA PHARMA INC
Ingredients PHENYTOIN SODIUM PHENYTOIN SODIUM
Strength(s) 100MG 100MG
Dosage form(s) CAPSULE CAPSULE
Route of administration ORAL ORAL ORAL ORAL
Packaging size 1000 BTL 1000 BTL
ATC code N03AB N03AB
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-06-01 2020-06-01
Estimated end date 2020-07-24 2020-07-04
Actual end date 2020-07-10
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments